Simona Borštnar

Pooled Analysis of Prognostic Impact of Urokinase-Type Plasminogen Activator and Its Inhibitor PAI-1 in 8377 Breast Cancer Patients

Maxime P. Look, Wim L.J. van Putten, Michael J. Duffy et al. · JNCI Journal of the National Cancer Institute · 2002 · 600 citations · Full text

Interrupting Endocrine Therapy to Attempt Pregnancy after Breast Cancer

Ann H. Partridge, Samuel M. Niman, Monica Ruggeri et al. · New England Journal of Medicine · 2023 · 202 citations · Full text

Who are the women who enrolled in the POSITIVE trial: A global study to support young hormone receptor positive breast cancer survivors desiring pregnancy

Ann H. Partridge, Samuel M. Niman, Monica Ruggeri et al. · The Breast · 2021 · 54 citations · Full text

Prognostic Value of the Urokinase-Type Plasminogen Activator, and its Inhibitors and Receptor in Breast Cancer Patients

Simona Borštnar, Ivan Vrhovec, Branka Svetic et al. · Clinical Breast Cancer · 2002 · 45 citations

Urology, Oncology, Breast Oncology +12

Full population results from the core phase of CompLEEment-1, a phase 3b study of ribociclib plus letrozole as first-line therapy for advanced breast cancer in an expanded population

Michelino De Laurentiis, Simona Borštnar, Mario Campone et al. · Breast Cancer Research and Treatment · 2021 · 33 citations · Full text